Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Synergistic effect of a combination of granulocyte macrophage colony-stimulating factor and thymosin ÃŽÂ±1 on Lewis lung cancer transplanted tumor in mice

Haiyan Lan¹ , Yanrong Hao¹, Yanru Lv¹, Guangyu Li², Yuncong Mo³, Cheng Zheng², Yuanfa Li²

¹Department of Oncological Internal Medicine, People's Hospital of Guangxi Zhuang Automous Region; ²Department of Andrology; ³Department of Nuclear Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, PR China.

For correspondence:- Haiyan Lan Email: d157ox@163.com

Accepted: 26 January 2020 Published: 30 April 2020

Citation: Lan H, Hao Y, Lv Y, Li G, Mo Y, Zheng C, et al. Synergistic effect of a combination of granulocyte macrophage colony-stimulating factor and thymosin ÃŽÂ±1 on Lewis lung cancer transplanted tumor in mice. Trop J Pharm Res 2020; 19(4):759-764 doi: 10.4314/tjpr.v19i4.12

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the synergistic effect of a combination of granulocyte-macrophage colony-stimulating factor and thymosin-α1 on the treatment of Lewis lung cancer transplanted tumor.

Methods: C57BL/6 mice were used. A mouse model of Lewis lung cancer was established using Lewis lung cancer cell lines. The mice were randomly divided into blank control group, polyene taxol (DTX) group, DTX thymosin α1 (Tα-1) group, and DTX granulocyte-macrophage colony-stimulating factor (GM-CSF) group, with 8 mice per group. The degree of tumor inhibition, thymus mass, thymus index, spleen mass, spleen index, IL-6, TNF-1, IFN-1, CD4⁺, CD8⁺ T cells and the ratio of CD4⁺/CD8⁺ were determined by ELISA and flow cytometry.

Results: Body mass, thymus mass, thymus index, spleen mass, spleen index, IL-6, TNF-1, IFN-1, CD4⁺, CD8⁺ T cells and the ratio of CD4⁺/CD8⁺ in DTX + Tα-1 group, DTX + GM-CSF group and DTX + Tα-1 + GM-CSF group were significantly elevated (p < 0.05), relative to the corresponding levels in DTX mice (p < 0.05). Body mass, degree of tumor inhibition, thymus mass, thymus index, spleen mass, spleen index, IL-6, TNF-1, IFN-1, CD4, CD8 T cells and CD4⁺/CD8⁺ ratio in DTX + Tα-1 + GM-CSF mice were significantly elevated, relative to the DTX + Tα-1 and DTX + GM-CSF groups (p < 0.05). The state of the tumor was significantly improved in the DTX + Tα-1 and DTX + GM-CSF mice.

Conclusion: A combination treatment of GM-CSF, Tα-1 and DEX effectively enhances the resistance of mice and suppresses chemotherapy-induced decrease in body weight. This finding may be of clinical significance.

Keywords: Granulocyte macrophage, Colony-stimulating factor, Thymosin, Docetaxel, Lewis lung cancer, Transplanted tumor